Clinical Perspective and Recent Development of PET Radioligands for Imaging Cerebral Nicotinic Acetylcholine Receptors

PET Clinics

Volumn 4, Issue 1, 2009, Pages 89-100

  Horti, Andrew G ^a   Wong, Dean F ^b  

^a PET Center   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

nAChR; Nicotine; PET; Positron emission tomography; Radioligands

Indexed keywords

2 (6 FLUORO 5 PHENYLPYRIDIN 3 YL) 7 AZA BICYCLO[2.2.1]HEPTANE; 2 [6 FLUORO 5 (4 FLUOROPHENYL)PYRIDIN 3 YL] 7 AZA BICYCLO[2.2.1]HEPTANE; 2 CHLORO 5 [(1 METHYLPYRROLIDIN 2 YL)METHOXY] 3 [2 (PYRIDIN 4 YL)VINYL]PYRIDINE; 3 (2 AZETIDINYLMETHOXY)PYRIDINE; 3 (6 FLUOROHEX 1 YNYL) 5 [(1 METHYLPYRROLIDIN 2 YL)METHOXY]PYRIDINE; 6 (6 FLUOROPYRIDIN 3 YL) 8 AZA BICYCLO[3.2.1]OCTANE; 7 METHYL 2 EXO (3 IODO 5 PYRIDINYL) 7 AZABICYLO[2.2.1]HEPTANE; CARBON 11; EPIBATIDINE; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; JHU 85157; JHU 85208; JHU 85270; JHU 86358; JHU 86428; JHU 86430; JHU 87522; NICOTINIC RECEPTOR; NIFENE; RADIOLIGAND; UNCLASSIFIED DRUG; WATER O 15;

BINDING AFFINITY; BRAIN REGION; DRUG STRUCTURE; HUMAN; MEDICAL RESEARCH; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEPTOR BINDING; REVIEW; RHESUS MONKEY;

EID: 68549096228     PISSN: 15568598     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpet.2009.04.014     Document Type: Review

References (59)

1. 11C]-nicotine in the brains of rhesus monkey. An attempt to study nicotinic receptors in vivo. J Neural Transm Park Dis Dement Sect 1 3 (1989) 195-205
2. 11C]nicotine binding assessed by PET: a dual tracer model evaluated in the rhesus monkey brain. Alzheimer Dis Assoc Disord 12 3 (1998) 238-246
3. Muzic Jr. R.F., Berridge M.S., Friedland R.P., et al. PET quantification of specific binding of carbon-11-nicotine in human brain. J Nucl Med 39 12 (1998) 2048-2054
4. Grunwald F., Biersack H.J., and Kuschinsky W. Nicotine receptor mapping. Eur J Nucl Med 23 8 (1996) 1012-1014
5. 18F]F-A85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans. FASEB J 17 10 (2003) 1331-1333
6. 18F-fluoro-A-85380 in healthy volunteers. J Nucl Med 44 4 (2003) 596-601
7. 18)F]fluoro-A-85380 and the multiinjection approach. J Cereb Blood Flow Metab 28 (2007) 172-189
8. 18F-fluoro-A-85380 and PET. J Nucl Med 46 2 (2005) 240-247
9. 18F]F-A85380. Neuroimage 39 2 (2008) 717-727
10. * nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study. Nucl Med Biol 34 3 (2007) 331-342
11. Ellis J.R., Nathan P.J., Villemagne V.L., et al. Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta(2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[ (18)F]Fluoro-A-85380 PET. Psychopharmacology (Berl) 202 1-3 (2009 Jan) 79-91 Epub 2008 Oct 24
12. 18F]fluoro-A-85380 PET study. Neurobiol Learn Mem 90 2 (2008) 404-412
13. 18F]F-A-85380 PET. Nucl Med Biol 32 6 (2005) 585-591
14. Picard F., Bruel D., Servent D., et al. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain 129 Pt 8 (2006) 2047-2060
15. Sabri O., Kendziorra K., Wolf H., et al. Acetylcholine receptors in dementia and mild cognitive impairment. Eur J Nucl Med Mol Imaging 35 Suppl 1 (2008) S30-S45
16. * nicotinic acetylcholine receptors in the human brain. Neurosci Lett 430 1 (2008) 34-37
17. 18F]Fluoro-A-85380, a new PET tracer for the nicotinic acetylcholine receptor: studies in the human brain and in vivo demonstration of specific binding in white matter. Synapse 53 3 (2004) 184-189
18. 123)I]iodo-3-(2-azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokers. Synapse 63 4 (2009) 339-358
19. Vaupel D.B., Tella S.R., Huso D.L., et al. Pharmacological and toxicological evaluation of 2-fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a ligand for imaging cerebral nicotinic acetylcholine receptors with positron emission tomography. J Pharmacol Exp Ther 312 1 (2005) 355-365
20. Horti A.G., and Villemagne V.L. The quest for Eldorado: development of radioligands for in vivo imaging of nicotinic acetylcholine receptors in human brain. Curr Pharm Des 12 30 (2006) 3877-3900
21. Gundisch D. Nicotinic acetylcholine receptors and imaging. Curr Pharm Des 6 11 (2000) 1143-1157
22. Sihver W., Langstrom B., and Nordberg A. Ligands for in vivo imaging of nicotinic receptor subtypes in Alzheimer brain. Acta Neurol Scand Suppl 176 (2000) 27-33
23. Sihver W., Nordberg A., Langstrom B., et al. Development of ligands for in vivo imaging of cerebral nicotinic receptors. Behav Brain Res 113 1-2 (2000) 143-157
24. Volkow N.D., Ding Y.S., Fowler J.S., et al. Imaging brain cholinergic activity with positron emission tomography: its role in the evaluation of cholinergic treatments in Alzheimer's dementia. Biol Psychiatry 49 3 (2001) 211-220
25. Ding Y.S., and Fowler J. New-generation radiotracers for nAChR and NET. Nucl Med Biol 32 7 (2005) 707-718
26. Brody A.L., Mandelkern M.A., London E.D., et al. Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry 63 8 (2006) 907-915
27. 123I]5-I-A-85380. Synapse 48 3 (2003) 116-122
28. 18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors. Life Sci 67 4 (2000) 463-469
29. Ding Y.S., Liu N., Wang T., et al. Synthesis and evaluation of 6-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine as a PET tracer for nicotinic acetylcholine receptors. Nucl Med Biol 27 4 (2000) 381-389
30. 18F]Fluoro-A-85380: an in vivo tracer for the nicotinic acetylcholine receptor. Nucl Med Biol 27 1 (2000) 51-56
31. Chefer S.I., Pavlova O.A., Zhang Y., et al. NIDA522131, a new radioligand for imaging extrathalamic nicotinic acetylcholine receptors: in vitro and in vivo evaluation. J Neurochem 104 (2008) 306-315
32. Zhang Y., Pavlova O.A., Chefer S.I., et al. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography. J Med Chem 47 10 (2004) 2453-2465
33. Paterson D., and Nordberg A. Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61 1 (2000) 75-111
34. Villemagne V.L., Musachio J.L., and Scheffel U. Nicotine and related compounds as PET and SPECT ligands. In: Arneric S.P., and Brioni J.D. (Eds). Neuronal nicotinic receptors, pharmacology and therapeutic opportunities (1999), Johns Wiley & Sons, New York 235-250
35. Abreo M.A., Lin N.H., Garvey D.S., et al. Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. J Med Chem 39 4 (1996) 817-825
36. Spande T.F., Garraffo H.M., Edwards M.W., et al. Epibatidine: a novel (chloropyridyl)azabicycloheptane with potent analgesic activity from an Ecuadoran poison frog. J Am Chem Soc 114 9 (1992) 3475-3478
37. 11C]methyl-2-(S)-pyr rolidinyl)methoxy]pyridine, a high affinity ligand for studying nicotinic acetylcholine receptors by positron emission tomography. Bioorg Med Chem 9 11 (2001) 3055-3058
38. Brown L.L., Kulkarni S., Pavlova O.A., et al. Synthesis and evaluation of a novel series of 2-chloro-5-(1-methyl-2-(S)-pyrrolidinyl)methoxy)-3-(2-(4-pyridinyl)vinyl ) pyridine analogues as potential positron emission tomography imaging agents for nicotinic acetylcholine receptors. J Med Chem 45 13 (2002) 2841-2849
39. Brown L., Chefer S., Pavlova O., et al. Evaluation of 5-(2-(4-pyridinyl)vinyl)-6-chloro-3-(1-methyl-2-(S)-pyrrolidinylmethoxy) pyridine and its analogues as PET radioligands for imaging nicotinic acetylcholine receptors. J Neurochem 91 3 (2004) 600-612
40. Gao Y., Ravert H.T., Kuwabara H., et al. Synthesis and biological evaluation of novel carbon-11 labeled pyridyl ethers: candidate ligands for in vivo imaging of nicotinic acetylcholine receptors (nAChRs) with positron emission tomography. Bioorg Med Chem 17 13 (2009 Jul 1) 4367-4377 Epub 2009 May 15
41. 11C]JHU85270), a potent ligand for nicotinic acetylcholine receptor imaging by positron emission tomography. Appl Radiat Isot 65 8 (2007) 947-951
42. 18)F-nifene: a measure of acetylcholine competition. Synapse 61 1 (2007) 29-36
43. 18F-nifene) in rodents and imaging by PET in nonhuman primate. Nucl Med Biol 33 3 (2006) 295-304
44. Wei Z.L., Xiao Y., Yuan H., et al. Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits. J Med Chem 48 6 (2005) 1721-1724
45. Kozikowski A.P., Chellappan S.K., Henderson D., et al. Acetylenic pyridines for use in PET imaging of nicotinic receptors. ChemMedChem 2 1 (2006) 54-57
46. Spang J.E., Bertrand S., Westera G., et al. Chemical modification of epibatidine causes a switch from agonist to antagonist and modifies its selectivity for neuronal nicotinic acetylcholine receptors. Chem Biol 7 7 (2000) 545-555
47. Carroll F.I., Ma W., Yokota Y., et al. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3′-substituted deschloroepibatidine analogues. Novel nicotinic antagonists. J Med Chem 48 4 (2005) 1221-1228
48. Ding Y.S., Kil K.E., Lin K.S., et al. A novel nicotinic acetylcholine receptor antagonist radioligand for PET studies. Bioorg Med Chem Lett 16 4 (2006) 1049-1053
49. Badio B., Shi D., Garraffo H.M., et al. Antinociceptive effects of the alkaloid epibatidine-further-studies on involvement of nicotinic receptors. Drug Dev Res 36 1 (1995) 46-59
50. Gao Y., Horti A.G., Kuwabara H., et al. Derivatives of (-)-7-methyl-2-(5-(pyridinyl)pyridin-3-yl)-7-azabicyclo[2.2.1]heptane are potential ligands for positron emission tomography imaging of extrathalamic nicotinic acetylcholine receptors. J Med Chem 50 16 (2007) 3814-3824
51. Gao Y., Horti A.G., Kuwabara H., et al. New synthesis and evaluation of enantiomers of 7-methyl-2-exo-(3′-iodo-5′-pyridinyl)-7-azabicyclo[2.2.1]hep tane as stereoselective ligands for PET imaging of nicotinic acetylcholine receptors. Bioorg Med Chem Lett 18 23 (2008) 6168-6170
52. Huang Y., Zhu Z., Xiao Y., et al. Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptors. Bioorg Med Chem Lett 15 19 (2005) 4385-4388
53. Carroll F.I., Ware R., Brieaddy L.E., et al. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2′-fluoro-3′-(substituted phenyl)deschloroepibatidine analogues. Novel nicotinic antagonist. J Med Chem 47 18 (2004) 4588-4594
54. 18F]F2PhEP, two new epibatidine-based radioligands: evaluation for imaging nicotinic acetylcholine receptors in baboon brain. Synapse 61 9 (2007) 764-770
55. 18)F]FPhEP, a novel alpha(4)beta(2)-selective, epibatidine-based antagonist for PET imaging of nicotinic acetylcholine receptors. Bioorg Med Chem 14 11 (2006) 3848-3858
56. Deuther-Conrad W., Patt J.T., Lockman P.R., et al. Norchloro-fluoro-homoepibatidine (NCFHEB) - a promising radioligand for neuroimaging nicotinic acetylcholine receptors with PET. Eur Neuropsychopharmacol 18 3 (2008) 222-229
57. 18F]norchloro-fluoro-homoepibatidine. Synapse 62 3 (2008) 205-218
58. Deuther-Conrad W., Patt J.T., Feuerbach D., et al. Norchloro-fluoro-homoepibatidine: specificity to neuronal nicotinic acetylcholine receptor subtypes in vitro. Farmaco 59 10 (2004) 785-792
59. 18F]fluoropyridin-2-yl)-5 ′-pyridinyl]-7-azabicyclo[2.2.1]heptane, a radiolabeled antagonist for cerebral nicotinic acetylcholine receptor (alpha4beta2-nAChR) with optimal positron emission tomography imaging properties. J Med Chem 51 15 (2008) 4751-4764